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BOOK REVIEWS
Cancer Surveys-Maturation and Differentiation in
Leukaemias Vol. 1. No 2. M.F. GREAVES (Guest
Editor). Series Editor, L.M. FRANKS. Oxford.
Oxford University Press, 346 pp, £12.
If the standard of presentation in this second issue
of Cancer Surveys is maintained, the series will
comprise a valuable collection of useful reviews of
benefit to clinicians and scientists alike. In this
volume Dr. Greaves has solicited contributions
from eminent workers in the field of
leukaemogenesis, discussing topics ranging from
regulator-dependent growth of normal and
leukaemic cells to the role of karyotypic changes,
viral-promoter mediated changes in cell behaviour,
and aberrant differentiation programmes expressed
by leukaemic cells. In his introduction, Greaves
rightly points out that "the success of the newer-
(research)-developments will depend critically on a
synthesis of the ideas and methods used by different
groups." This is particularly true in the field of
normal h4emopoiesis and leukaemogenesis which in
the past >decade has witnessed an explosion in the
cell biological, biochemical and molecular biological
assay systems available for analyzing the cell
surface, intracellular and genomic changes
occurring during growth and differentiation. The
ultimate goal of course, is to understand the
regulatory networks concerned with control of
growth and development of stem- and lineage-
restricted cells and the perturbations of this
network during leukaemic transformation.
Beug, Hayman and Graf discuss their work with
avian retroviruses, the possible mechanism of
lineage-restricted transformation by viral "sub-
type", and introduce the oncogene concept. It may
be thought by some that chicken leukaemias are
not relevant to understanding the human disease!
Far from it. The cellular equivalent to the viral
oncogenes are not expressed only in birds, but in
human cells as well, and recent publications testify
to the possible importance of these genes and their
products in transformed human cells! This work is
discussed in more detail in a chapter by Varmus
who concludes that viruses which do not carry their
"own" oncogene may transform cells by activating
cellular oncogenes. They do this by acting as gene
promoters-affecting the transcriptional activity of
the region of DNA in which they have been
inserted.
There is also a chapter by Harrison on
differentiation of the murine erythroleukaemias.
(For newcomers to this field, I can recommend the
article as a thorough and competent review of this
complicated field. The article discusses the possible
mode of action, and target cell specificity of several
erythroleukaemia-inducing viruses and describes the
various ways in which the transformed cells can be
induced to express a differentiation programme.
Together with the article by Sachs-on the
development of myeloid leukaemia cells-this work
raises real hope for the future in exploiting the
differentiation ability of many leukaemias. In
leukaemic cells, growth and differentiation are
indeed uncoupled but the change is not irreversible.
In appropriate circumstances, differentiation (clonal
senescence) can be induced. In the article by
McCulloch et al. (the "godfather" of modern
experimental haematology) is described the concept
that leukaemic cell growth is determined by a
balance between self-renewal and determination,
but that as a consequence of determination there is
"a sequential expression of differentiation markers
in patterns dissimilar from those of normal
haemopoiesis." While several groups would
disagree with this model, the suggestion put
forward by McCulloch that the extent of deviation
from the normal pattern may be correlated with the
aggressiveness of the leukaemic cell population is
an interesting one and requires further
investigation. Finally, the article by Klein discusses
the karyotypic changes seen in some leukaemias
arising in mouse and man. In particular, both
translocations and trisomies may result in the
activation of oncogenes. When read in the context
of the work reported by Beug and Varmus, the
model is beautiful in its simplicity.
In conclusion, a readable book, well worth
buying.
T.M. Dexter,
Division of Experimental Haematology,
Paterson Laboratories,
Christie Hospital & Holt Radium Institute,
Manchester M20 9BX.
Assessment of Immune Status by the Leukocyte
Adherence Inhibition Test (Ed D.M.P. THOMSON).
London. Academic Press, 380 pp, 1982, £29.00.
Since first described the leuckocyte adherence
inhibition assay (LAI) has met with some criticism.
This is to be expected for any assay which claims to
have diagnostic significance for malignant disease,
particularly when introduced at a time (1972) when
confidence in the role of cell-mediated immunity
against human neoplasia was at a low ebb. Here
was an assay (based upon antigen-specific reduction
of adherence to plastic or glass surfaces of
leukocytes) which claimed to demonstrate organ-